Your fact-checks will appear here
Comparison of semaglutide with other GLP-1RAs and SGLT2 inhibitors in terms of efficacy for weight loss and glycaemic control
Randomized trials and pooled analyses show semaglutide delivers larger average reductions in HbA1c and body weight than many other GLP‑1 receptor agonists (GLP‑1RAs), with head‑to‑head meta‑analysis f...
Prescription GLP‑1 receptor agonists are clinically tested, regulated drugs that mimic the GLP‑1 hormone to slow gastric emptying, reduce appetite and produce substantial, trial-proven weight loss, wh...
Tirzepatide — a dual GIP and GLP‑1 receptor agonist — produces larger average weight losses in randomized trials than single‑receptor GLP‑1 drugs such as semaglutide and liraglutide, with dose‑depende...